Number of Patients With Evaluable Data
| Parameter . | No. of . | Parameter . | No. of . |
|---|---|---|---|
| . | Patients . | . | Patients . |
| PB | |||
| WBC | 110 | Spleen size in cm | 106 |
| Differential count | 100 | Liver size in cm | 105 |
| Platelets* | 106 | Karyotype | 98 |
| Hb* | 107 | LDH† | 82 |
| MCV | 79 | Ig G† | 81 |
| Reticulocytes | 60 | IgM† | 79 |
| Hb F | 91 | IgA† | 79 |
| BM | |||
| Cell content | 100 | Antinuclear antibodies† | 29 |
| Megakaryocytes | 89 | Direct Coombs test | 22 |
| Differential count | 92 | Lysozyme† | 29 |
| Parameter . | No. of . | Parameter . | No. of . |
|---|---|---|---|
| . | Patients . | . | Patients . |
| PB | |||
| WBC | 110 | Spleen size in cm | 106 |
| Differential count | 100 | Liver size in cm | 105 |
| Platelets* | 106 | Karyotype | 98 |
| Hb* | 107 | LDH† | 82 |
| MCV | 79 | Ig G† | 81 |
| Reticulocytes | 60 | IgM† | 79 |
| Hb F | 91 | IgA† | 79 |
| BM | |||
| Cell content | 100 | Antinuclear antibodies† | 29 |
| Megakaryocytes | 89 | Direct Coombs test | 22 |
| Differential count | 92 | Lysozyme† | 29 |